Keywords:
Abdomen, Oncology, Gastrointestinal tract, CT, MR, Staging, Cancer, Cirrhosis
Authors:
S. Fiore, E. Caramia, M. Gatti, L. J. Pavan, S. Molinaro, A. Depaoli, R. Faletti, P. Fonio; Turin/IT
DOI:
10.1594/ecr2018/C-1169
Aims and objectives
Hepatocellular cancer (HCC) is the second cancer death cause in the world.
Its identification and correct characterization are very important because it’s a virtually curable pathology in early stage.
Several american and european guidelines (AASLD [1],
EASL-EORTC [2],
ESMO-ESDO [3]) for HCC management exist and they agree about the use of multiphasic Computed Tomography (CT) or extracellular contrast medium dinamic Magnetic Resonance Imaging (MRI) as second level methodicals to better characterize a focal hepatic lesion discovered by Ultrasonography (US) in a cirrhotic patient.
The only different point of view comes from japanese guidelines (JSH) [4],
that suggest hepatobiliary contrast medium MRI (Gd-EOB-DTPA MRI) as first methodical among second level exams; Bologna Team (Renzulli et al.) recently proposed a new diagnostic algorithm based on these asiatic guidelines [5].
The aim of our study is to evaluate performances of Gd-EOB-DTPA MRI in patients under surveillance for cirrhosis,
with suspicious HCC after CT.